Ron Bentsur - Jun 7, 2023 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Chairman & CEO, Director, 10%+ Owner
Signature
/s/ Ron Bentsur
Stock symbol
NVCT
Transactions as of
Jun 7, 2023
Transactions value $
$6,108
Form type
4
Date filed
6/8/2023, 09:28 PM
Previous filing
Jun 1, 2023
Next filing
Jun 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Purchase $4K +230 +0.01% $17.41 3.23M Jun 7, 2023 Direct F1
transaction NVCT Common Stock Purchase $2.1K +120 +0% $17.53 3.23M Jun 8, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 426,759 shares of restricted stock.